|
|
|
|
|
|
|
|
|
|
Previous: PHARMACEUTICAL FORMULATIONS INC, 10-Q, 2000-06-16 |
Next: NATIONWIDE SEPARATE ACCOUNT TRUST, 485APOS, 2000-06-16 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUL-01-2000
<PERIOD-START> JUL-04-1999
<PERIOD-END> APR-01-2000
<CASH> 138,000
<SECURITIES> 0
<RECEIVABLES> 13,293,000
<ALLOWANCES> 331,000
<INVENTORY> 18,195,000
<CURRENT-ASSETS> 33,498,000
<PP&E> 38,495,000
<DEPRECIATION> 22,059,000
<TOTAL-ASSETS> 52,630,000
<CURRENT-LIABILITIES> 27,698,000
<BONDS> 4,610,000
0
2,500,000
<COMMON> 2,421,000
<OTHER-SE> 37,493,000
<TOTAL-LIABILITY-AND-EQUITY> 52,630,000
<SALES> 67,246,000
<TOTAL-REVENUES> 63,083,000
<CGS> 48,541,000
<TOTAL-COSTS> 58,310,000
<OTHER-EXPENSES> (69,000)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 3,875,000
<INCOME-PRETAX> 967,000
<INCOME-TAX> 327,000
<INCOME-CONTINUING> 640,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 640,000
<EPS-BASIC> (.02)
<EPS-DILUTED> (.02)
</TABLE>
|
|